search icon
  • Print
  • ShareThis
  • Text Size
  • View All Increased Federal Funding Comments

  • Search More Comments
    12/30/2013

    HIVMA and IDSA Weigh In with the Administration on FY2015 Funding Priorities

    IDSA and HIVMA weighed in on the Administration’s finalization of the FY 2015 PBR and discussions with Congress over a long-term deficit reduction plan, requesting that the biomedical research and public health functions of the federal government are made whole with pre-sequestration funding levels for relevant agencies.
    10/28/2013

    IDSA-HIVMA Letter to FY14 Budget Conferees

    IDSA and HIVMA weighed in with the FY14 Budget Conferees urging the work towards a Fiscal Year (FY) 2014 Budget Resolution that returns the public health and biomedical research functions of the federal government to pre-sequestration levels.
    09/18/2013

    HIVMA Testimony for Special Committee on Aging (PDF)

    In conjunction with HIV and Aging Awareness Day, the Senate Special Committee on Aging is convening a hearing on HIV and Aging (Wednesday, September 18, 2013 2:00pm in Dirksen 562).  HIVMA Board Chair, Dr. Michael Horberg, submitted a written statement for the record, emphasizing the importance of continued robust support for research on HIV and aging, as well as continuation of the Ryan White program.
    03/13/2013

    Written Testimony to the House for Fiscal Year 2014 Appropriations

    Testimony submitted for the record to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY2014 funding levels for HIV/AIDS Programs, submitted by Dr. Michael Horberg on behalf of the HIV Medicine Association.
    12/07/2012

    IDSA-HIVMA letter to the Office of Management and Budget on funding priorities for FY2014

    HIVMA and IDSA leaders weighed in with the White House Office of Management and Budget (OMB) on federal funding priorities for fiscal year 2014. The joint letter to the OMB urges sustained investments in ID and HIV research and public health activities; development of new drugs, vaccines and diagnostics; and provision of high quality health care to reduce health care costs while saving lives and improving quality of life.
    09/10/2012

    IDSA-HIVMA Letter Opposing Sequestration

    HIVMA and IDSA leaders weighed in with Congress, urging action to prevent “sequestration”—across the board cuts to all federal agencies—from occurring before January 1, 2013. The letter highlights the devastating impact such cuts would have for the nation’s public health infrastructure and biomedical research enterprise, which have already borne a disproportionate share of budget cuts in recent years.
    06/07/2012

    HIVMA Comments in Advance of Committee Action on the Senate FY2013 LHHS and Education Appropriations Bill

    HIVMA Board Chair, Dr. Judith A. Aberg, weighed in with Senate appropriators on behalf of HIVMA, in anticipation of Committee action on the Senate FY2013 Labor, Health and Human Services and Education appropriations bill next week. The letter urges the highest possible levels of funding for key domestic and international HIV/AIDS programs.
    03/28/2012

    Written Testimony to the House for Fiscal Year 2013 Appropriations

    Testimony Submitted for the Record to the Subcommittee on Labor, Health and Human Services, Education and Related Agencies on FY 2013 Appropriations for HIV/AIDS Programs Submitted by the HIV Medicine Association
    10/13/2011

    HIVMA and IDSA urge Congress to not eliminate the U.S. Military HIV Research Program

    IDSA & HIVMA sent a letter expressing grave concern about the proposed elimination of the $16 million Army Science and Technology funding line of the U.S. Military HIV Research Program (MHRP).
    09/09/2011

    Implications of HPTN 052 for the US Response to Domestic and Global AIDS

    HIVMA responds to the results of the HPTN 052 study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), which found that HIV-infected men and women with relatively healthy immune systems who received immediate oral antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners and were more than 40 percent less likely to experience a clinical event than those whose treatment was delayed.
    09/08/2011

    HIVMA Urges Super Committee to Protect our nation's public health and health care safety-net

    HIVMA sent a letter regarding the mission and upcoming work of the Joint Select Committee on Deficit Reduction outlining four prinicpals to protect investments critical to our nation’s health.
    07/15/2011

    Joint Budget Statement of IDSA and HIVMA

    In a letter to the President and Congressional Leadership, IDSA and HIVMA outlined their position regarding the current deficit reduction negotiations and urged the leaders to protect investments critical to our nation's health.
    05/27/2011

    HIVMA Testimony to the Senate for Fiscal Year 2012 Appropriations

    Testimony Submitted for the Record to the Subcommittee on Labor, Health and Human Services, Education and Related Agencies on FY 2012 Appropriations for HIV/AIDS Programs.
    04/20/2011

    HIVMA Testimony to the House for Fiscal Year 2012 Appropriations

    Testimony submitted for the record to the House subcommittee on Labor, Health and Human Services, Education and Related Agencies on FY 2012 appropriations for HIV/AIDS programs.
    07/13/2009

    IDSA, HIVMA Support Repeal of 20 Year-Old Ban on Needle Exchange

    In a joint letter U.S. House Appropriations Committee, HIVMA and IDSA expressed strong support for retaining the historic repeal of the 20 year-old ban on federal funding for needle exchange programs.

    HIV Physician Scientists and Advocacy Groups Urge Secretary Kerry to Advocate For Funding for PEPFAR and the Global Fund

    HIV Physician Scientists and Advocacy Groups Urge Secretary Kerry to Advocate For Funding for PEPFAR and the Global Fund

 

Average 0 out of 5

| IDSA | Contact Us

© Copyright HIVMA 2012 HIV Medicine Association

Full Site Mobile Site